MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-19-0031815
Aiwa Pharmaceuticals Private Limited
Aiwa Pharmaceuticals Private Limited - trading in Karanjade, Maharashtra, India. Directors, charges & compliance details.
Revenue · FY 2025
₹23.79 Lakh
▼ 32% YoY
Net profit · FY 2025
₹4,897
Net margin 0.2%
EBITDA · FY 2025
₹94,513
EBITDA margin 4%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹10,000
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Aiwa Pharmaceuticals Private Limited
Data last updated:
Aiwa Pharmaceuticals Private Limited is a private limited company based in Karanjade, Maharashtra, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 23 November 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2020PTC350526.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹10,000. It is led by directors Nagarajan Guruprasath and Malluram Shanthi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sh 12 Ganesh Vihar Plot 128 Sector 4, Karanjade, Maharashtra, India – 410206.
As per the financials filed for FY 2025, the company reported a revenue of ₹23.79 Lakh, a decline of 32% compared to the previous year. For the same year it recorded a net profit of ₹4,897 (net margin 0.2%) and EBITDA of ₹94,513 (EBITDA margin 4%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years.
Aiwa Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0031815).
Company details
CIN U51909MH2020PTC350526
Registration Number 350526
Incorporation Date 23 November 2020
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-19-0031815
Recognitions & Rankings of Aiwa Pharmaceuticals
Contact details
Aiwa Pharmaceuticals Private Limited's registered office is in Karanjade, Maharashtra.
- Registered AddressSh 12 Ganesh Vihar Plot 128 Sector 4, Karanjade, Maharashtra, India – 410206
- IndustryTrading, Specialty, Wholesale
Comprehensive company report
Aiwa Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Aiwa Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Aiwa Pharmaceuticals Private Limited, buy the company report.
Financials of Aiwa Pharmaceuticals Private Limited
FY 2025 filings availableAiwa Pharmaceuticals Private Limited reported revenue of ₹23.79 Lakh (down 32% YoY) for FY 2025.
Revenue · FY 2025
₹23.79 Lakh ▼ 32%
Net profit · FY 2025
₹4,897 margin 0.2%
EBITDA · FY 2025
₹94,513 margin 4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 32%
3 years · compounded
▲ 1%
EBITDA CAGR growth
1 year
▼ 22%
3 years · compounded
▼ 28%
Revenue fell 32% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 1%. EBITDA fell 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹94,513 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4,897 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aiwa Pharmaceuticals Private Limited, buy the company report.
Board of directors of Aiwa Pharmaceuticals Private Limited
Aiwa Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nagarajan Guruprasath | Director | 23 Nov 2020 | 5 Years 11 Months | Current |
| Malluram Shanthi | Director | 23 Nov 2020 | 5 Years 11 Months | Current |
Legal cases
No court or tribunal cases involving Aiwa Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aiwa Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Aiwa Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Aiwa Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Malluram Shanthi was appointed as Director on 23 Nov 2020.
AGM
Aiwa Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Aiwa Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Appointed
Malluram Shanthi was appointed as Director.
Appointed
Nagarajan Guruprasath was appointed as Director.
Incorporation
23 Nov 2020
Aiwa Pharmaceuticals Private Limited was registered on 23 Nov 2020 with Roc Mumbai Ii & aged 5 years 11 months as per MCA records.
Frequently asked questions
Aiwa Pharmaceuticals is an active private limited company based in Karanjade, Maharashtra, India. The company works in specialty, within the trading industry. It was incorporated on 23 November 2020 (6+ years old) and is registered under CIN U51909MH2020PTC350526.
Aiwa Pharmaceuticals has 2 current directors:
- Nagarajan Guruprasath - Director
- Malluram Shanthi - Director
The latest financial statements of Aiwa Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Aiwa Pharmaceuticals is U51909MH2020PTC350526. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aiwa Pharmaceuticals was incorporated on 23 November 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
Malluram Shanthi was appointed as Director on 23 Nov 2020. Nagarajan Guruprasath was appointed as Director on 23 Nov 2020.
Yes, Aiwa Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-19-0031815).
The registered office of Aiwa Pharmaceuticals is at Sh 12 Ganesh Vihar Plot 128 Sector 4, Karanjade, Maharashtra, India – 410206.
Aiwa Pharmaceuticals operates in the trading industry, in the specialty segment.
Aiwa Pharmaceuticals can be reached at its registered office: Sh 12 Ganesh Vihar Plot 128 Sector 4, Karanjade, Maharashtra, India – 410206.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages